Exagen (XGN) Accumulated Expenses (2018 - 2026)

Exagen (XGN) has reported Accumulated Expenses for 9 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $4.8 million, down 3.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (down 3.56% YoY), and the FY2025 annual result was $6.3 million, down 8.52% from the prior year.
• Accumulated Expenses was $4.8 million for Q1 2026 at Exagen, down from $6.3 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $7.5 million in Q4 2023 and troughed at $4.8 million in Q1 2026.
• Average Accumulated Expenses over 5 years is $6.0 million, with a median of $6.0 million recorded in 2024.
• Year-over-year, Accumulated Expenses retreated 21.67% in 2022 and soared 40.85% in 2023.
• Over 5 years, Accumulated Expenses stood at $5.3 million in 2022, then surged by 40.85% to $7.5 million in 2023, then dropped by 8.17% to $6.9 million in 2024, then fell by 8.52% to $6.3 million in 2025, then retreated by 24.58% to $4.8 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $4.8 million in Q1 2026, $6.3 million in Q4 2025, and $5.7 million in Q3 2025.